Preclinical Evaluation of Antiurolithiatic Activity of <i>Viburnum opulus</i> L. on Sodium Oxalate-Induced Urolithiasis Rat Model

<table>Microscopic view of urine samples (the original magnification is <svg height="8.5" id="M26" style="vertical-align:-0.3135pt" version="1.1" viewbox="0 0 10.1 8.5" width="10.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,8.438)"><path d="M528 54l-36 -38l-198 201l-198 -201l-36 38l197 200l-197 201l36 38l198 -202l198 202l36 -38l-197 -201z" id="xD7"></path></g>
</svg>400). Data are representative of 6 animals per group; LCJVO treated group.</table>

Evidence-Based Complementary and Alternative Medicine

fig3

Figure 3

Figure 3: Preclinical Evaluation of Antiurolithiatic Activity of <i>Viburnum opulus</i> L. on Sodium Oxalate-Induced Urolithiasis Rat Model 

Evidence-Based Complementary and Alternative Medicine

Preclinical Evaluation of Antiurolithiatic Activity of Viburnum opulus L. on Sodium Oxalate-Induced Urolithiasis Rat Model

Figure 3